US nuclear technology company Oklo is planning to build on the rapid deployment of the Groves Isotope Test Reactor in Texas with Groves-2 Forge, an isotope production and processing pilot facility.
Oklo said Groves-2 Forge will build on the demonstration experience from the Groves Isotope Test Reactor while including capabilities to produce, process and purify critical isotopes.
Groves-2 Forge will have reactor irradiation with hot-cell processing capabilities, including isotope separation, product recovery, packaging and transportation. Its focus will be on lutetium-177 and other therapeutic isotopes for use in manufacturing radiopharmaceutical treatments.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
